![]() |
市場調查報告書
商品編碼
1876620
具備人工智慧分析功能的數位聽診器市場機會、成長促進因素、產業趨勢分析及2025-2034年預測Digital Stethoscope with AI Analysis Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034 |
||||||
2024 年全球具有人工智慧分析功能的數位聽診器市值為 6,210 萬美元,預計到 2034 年將以 5.7% 的複合年成長率成長至 1.065 億美元。

由於心血管和呼吸系統疾病病例的增加,以及人工智慧的整合應用、遠距醫療的蓬勃發展、手持式診斷設備的普及以及對預防性醫療保健的日益重視,市場正在不斷擴張。配備人工智慧的數位聽診器為醫療專業人員提供先進的診斷功能,支援疾病早期檢測、持續的患者監測以及人工智慧輔助的臨床決策。產品包括有管式和無管式兩種型號,並提供有線或無線配置,利用雲端或設備端人工智慧技術應用於心臟病學、肺病學及其他領域。遠距醫療和遠距監測計畫的激增使得人工智慧聽診器成為遠距會診、慢性病管理和家庭護理的必備工具。透過藍牙或Wi-Fi進行無線連接,可將資料即時傳輸到雲端平台,使醫生能夠快速做出明智的決策。聲學設計、訊號處理和降噪的創新顯著提高了這些設備的可靠性和精確度,使其診斷性能超越了傳統聽診器。
| 市場範圍 | |
|---|---|
| 起始年份 | 2024 |
| 預測年份 | 2025-2034 |
| 起始值 | 6210萬美元 |
| 預測值 | 1.065億美元 |
| 複合年成長率 | 5.7% |
預計到2034年,無導管聽診器市場將以6.2%的複合年成長率成長,這主要得益於其便攜性、無線功能以及與遠距醫療和家庭護理計畫的兼容性。無導管聽診器在保留傳統聲學原理的同時,融合了人工智慧分析和數位訊號處理技術,將創新與可靠的音質完美結合。這些設備廣泛應用於醫院、基層醫療中心和專科診所,在這些場所,高保真聽診對於準確的心肺診斷至關重要。
2024年,無線數位聽診器市佔率達到78.7%,預計在2025年至2034年間將達到8,070萬美元。其市場主導地位源於與藍牙、Wi-Fi和混合連接的無縫整合,從而能夠將資料即時傳輸至雲端平台和人工智慧分析系統。這種連接方式可支持遠距醫療、遠端監測和持續護理,有助於應對日益嚴重的心血管和肺部疾病負擔。
由於北美地區擁有先進的醫療基礎設施、創新醫療設備的高普及率以及完善的遠距醫療生態系統,預計到2024年,北美帶有人工智慧分析功能的數位聽診器市場佔有率將達到35.5%。心臟衰竭、心律不整、慢性阻塞性肺病和氣喘等疾病的高發生率推動了對早期精準診斷工具的需求。包括高保真麥克風、人工智慧聽診演算法、降噪技術和無線連接在內的技術進步,提升了醫院、基層醫療機構和家庭護理計畫的診斷能力。
全球人工智慧分析數位聽診器市場的主要參與者包括Aevice Health、Ai Health Highway、Eko Health、eKuore Medical、HD Medical、Lapsi Health、M3DICINE、Minttihealth、Sensi Cardiac、Solventum、Sonavi Labs、Steth IO、StethoMe和Thinklabs。這些公司透過在人工智慧演算法、聲學工程和無線連接方面的持續創新來鞏固其市場地位。他們正與醫院和遠距醫療服務提供者建立策略合作夥伴關係,以擴大產品應用範圍並展示其臨床療效。此外,各公司也積極投資於法規核准和報銷支持,以提高產品的可及性和可信度。產品多樣化、精準行銷活動和方便用戶使用的行動應用程式有助於將設備更好地融入日常醫療護理中。
The Global Digital Stethoscope with AI Analysis Market was valued at USD 62.1 million in 2024 and is estimated to grow at a CAGR of 5.7% to reach USD 106.5 million by 2034.

The market is expanding due to rising cases of cardiovascular and respiratory conditions, coupled with the integration of artificial intelligence, growth in telemedicine, increasing adoption of handheld diagnostic devices, and a stronger emphasis on preventive healthcare. Digital stethoscopes equipped with AI provide advanced diagnostic capabilities for healthcare professionals, supporting early disease detection, ongoing patient monitoring, and AI-assisted clinical decision-making. Products include both tube-type and tubeless models, with wired or wireless configurations, leveraging cloud-based or on-device AI for cardiology, pulmonary, and other applications. The surge in telemedicine and remote monitoring programs has made AI-enabled stethoscopes indispensable for remote consultations, chronic disease management, and home care. Wireless connectivity through Bluetooth or Wi-Fi facilitates real-time data transfer to cloud platforms, allowing physicians to make informed decisions quickly. Innovations in acoustic design, signal processing, and noise reduction have significantly improved the reliability and precision of these devices, surpassing traditional stethoscopes in diagnostic performance.
| Market Scope | |
|---|---|
| Start Year | 2024 |
| Forecast Year | 2025-2034 |
| Start Value | $62.1 Million |
| Forecast Value | $106.5 Million |
| CAGR | 5.7% |
The tubeless segment is projected to grow at a CAGR of 6.2% through 2034, driven by its portability, wireless functionality, and compatibility with telemedicine and home care programs. Tubeless stethoscopes maintain classical acoustic principles while incorporating AI-powered analysis and digital signal processing, combining innovation with reliable sound quality. These devices are widely adopted in hospitals, primary care centers, and specialty clinics where high-fidelity auscultation is essential for accurate cardiovascular and pulmonary diagnostics.
The wireless digital stethoscope segment held a 78.7% share in 2024 and is expected to reach USD 80.7 million during 2025-2034. Its dominance stems from seamless integration with Bluetooth, Wi-Fi, and hybrid connectivity, enabling real-time data transmission to cloud platforms and AI analytics systems. This connectivity supports telemedicine, remote monitoring, and continuous care, addressing the increasing burden of cardiovascular and pulmonary disorders.
North America Digital Stethoscope with AI Analysis Market held 35.5% share in 2024 owing to advanced healthcare infrastructure, high adoption of innovative medical devices, and a well-established telemedicine ecosystem. The prevalence of heart failure, arrhythmias, COPD, and asthma drives demand for early and accurate diagnostic tools. Technological advances, including high-fidelity microphones, AI auscultation algorithms, noise reduction, and wireless connectivity, enhance diagnostic capabilities across hospitals, primary care facilities, and home care programs.
Key players in the Global Digital Stethoscope with AI Analysis Market include Aevice Health, Ai Health Highway, Eko Health, eKuore Medical, HD Medical, Lapsi Health, M3DICINE, Minttihealth, Sensi Cardiac, Solventum, Sonavi Labs, Steth IO, StethoMe, and Thinklabs. Companies in the Digital Stethoscope with AI Analysis Market are strengthening their position through continuous innovation in AI algorithms, acoustic engineering, and wireless connectivity. They are forming strategic partnerships with hospitals and telemedicine providers to expand adoption and demonstrate clinical efficacy. Firms are also investing in regulatory approvals and reimbursement support to enhance accessibility and credibility. Product diversification, targeted marketing campaigns, and user-friendly mobile applications help increase device integration into routine care.